Erica Buoso

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 7

Top Topics

Oxidative Stress

Cognitive Decline

Tyrosine Kinase

Top Venues

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Mirco Masi, Alessandro Attanzio, Marco Racchi, Benjamin Wolozin, Sofia Borella, Fabrizio Biundo, Erica Buoso
Proteostasis Deregulation in Neurodegeneration and Its Link with Stress Granules: Focus on the Scaffold and Ribosomal Protein RACK1. Cells 11 (16) (2022)
Erica Buoso, Alessandro Attanzio, Fabrizio Biundo
Cellular Senescence in Age-Related Diseases: Molecular Bases and Therapeutic Interventions. Cells 11 (13) (2022)
Erica Buoso, Fabrizio Biundo, Alessandro Attanzio
New Therapeutic Approaches against Inflammation and Oxidative Stress in Neurodegeneration. Oxidative medicine and cellular longevity 2022 (2022)
Mirco Masi, Marco Racchi, Cristina Travelli, Emanuela Corsini, Erica Buoso
Molecular Characterization of Membrane Steroid Receptors in Hormone-Sensitive Cancers. Cells 10 (11) (2021)
Erica Buoso, Mirco Masi, Aideen Long, Camilla Chiappini, Cristina Travelli, Stefano Govoni, Marco Racchi
Ribosomes as a nexus between translation and cancer progression: Focus on ribosomal Receptor for Activated C Kinase 1 (RACK1) in breast cancer. British journal of pharmacology (2020)
Federica Finetti, Cristina Travelli, Jasmine Ercoli, Giorgia Colombo, Erica Buoso, Lorenza Trabalzini
Prostaglandin E2 and Cancer: Insight into Tumor Progression and Immunity. Biology 9 (12) (2020)
Mirco Masi, Enrico Garattini, Marco Bolis, Daniele Di Marino, Luisa Maraccani, Elena Morelli, Ambra A Grolla, Francesca Fagiani, Emanuela Corsini, Cristina Travelli, Stefano Govoni, Marco Racchi, Erica Buoso
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression. Oncogenesis 9 (12) (2020)